REG-Misys: Trading Statement <MSY.L>

FOR IMMEDIATE RELEASE
13 DECEMBER 2007
                                   MISYS plc                                   
Misys revenue and profit improvement on track; Healthcare business returns to
growth
Misys plc, (FTSE: MSY.L) the global application software and services company,
is today providing an update on its trading performance (unaudited,
like-for-like*) for the six months ended 30 November 2007. 
OVERVIEW
Misys has had an encouraging first half, with year-on-year revenue increasing
across the divisions, and exceeding our internal target. Our cost takeout
programme is on track, and we are reinvesting much of this into the business to
drive future revenue growth. We have rebalanced the portfolio and completed
disposals which enable us to focus on our core strengths in the high growth
areas of the markets we serve. We have a much improved financial structure and
have moved the business from a net debt to net cash position, providing a
strong base to build from.
Group revenue is expected to show percentage growth in the low single digits
(H1 2006: £223 million) and adjusted EPS** is expected to be in the range of
5.5p to 6.5p (H1 2006: 6.4p, including £10m profit (c. 2p) derived from Sesame
which has been sold).
Revenue growth in both Misys Banking and Misys Treasury & Capital Markets (TCM)
is expected to be in the mid-single-digit percentage range for the first half,
as compared to the same period last year. Misys Healthcare is expected to
report slight growth as compared to the same period last year. Misys Global
Services is included in the divisional performance and expected to report
half-year percentage revenue growth in the mid teens.
Commenting on performance, Mike Lawrie, Misys plc Chief Executive said:
"We are encouraged by first half revenue performance. We are on track with our
cost take out and margins have improved.
We have the right strategy in place and following the disposals made we now
have the right base to build from. We continue to move to a solution
orientation and our global services business is starting to get real traction
delivering value add services to customers. Our Healthcare business has
returned to growth and customers are responding positively to our new
offerings. Banking delivered solid growth driven by a number of new name
contracts. Treasury & Capital Markets continued to make good progress and grew
revenue.
The partnerships we have executed with major international leaders will help
drive increased growth, open markets which we previously could not access
effectively and increase our services capability.
We continue to monitor the situation aggressively but to date the global credit
market issues have not materially impacted our business. However, ILF order
intake in Treasury & Capital Markets was below our internal target and we
attribute that largely to sales execution issues, which we are addressing.
Total order intake for Treasury & Capital Markets was similar to the same
period last year.
It is early days and there remains much work to do but this is another data
point which demonstrates that we are beginning to make real progress."
BUSINESS PERFORMANCE
Misys Banking secured a number of valuable new name wins in the first half and
the Misys BankFusion development work continues to be on track. Misys Treasury
& Capital Markets continued to make progress with its market leading solution
offerings. Misys Healthcare has improved considerably and returned to growth as
the benefit of earlier corrective actions comes through. Misys Global Services
continues to ramp up and is making good progress with new service offerings.
MISYS HEALTHCARE
We are seeing evidence that the corrective actions taken to get the healthcare
business positioned for growth are having a positive effect. We rebalanced the
business portfolio to focus on our core strength in the US ambulatory market,
where we are a market leader. In October we launched Misys MyWay, the new
electronic medical record and practice management solution, which is available
as a hosted service and targeted at small physician practices. This has been
very well received by customers and we are encouraged by early orders.
PARTNERSHIPS
Continuing our theme of developing winning partnerships, we have made
significant further progress against this key strategic imperative. Key
partnerships announced in the period include: our global banking alliance with
SAP; our landmark deal with HCL for product development, services and joint go
to market opportunities in India and fast growing Asian economies where HCL has
chosen Misys as their preferred banking software provider; and our partnership
with Wipro Technologies where Wipro is building a centre of excellence around
Misys Opics in the Middle East, where there is strong demand.
The Misys and HCL partnership has already secured its first joint customer,
Maybank in Malaysia.
ECONOMIC CLIMATE
Misys' business model and global footprint have helped to insulate the Company
so far from turbulence in the macroeconomic climate. Misys Banking has not been
affected, it has a huge customer base and growing recurring revenue streams.
Spend on core banking products and services tends to be less discretionary as
they drive productivity and efficiency improvements as well as mitigating risk.
In addition, the majority of the Banking business comes from Tier 3 and 4 banks
in Asia, Africa and the Middle East. More than half of revenue in Misys
Treasury & Capital Markets is not dependent on new licence sales and this,
coupled with a strong footprint in emerging markets, particularly Asia, helps
to mitigate the effects that some competitors may face.
Misys will announce interim results on 24 January 2008.
* On a like for like basis which is at constant exchange rates for continuing
operations, excludes disposals and the incremental benefit of acquisitions.
**Adjusted EPS is calculated on a reported basis for continuing and
discontinued operations earnings, before exceptional items, gains and losses on
embedded derivatives, amortisation of acquired intangibles and the impact of
translation exchange differences recycled from reserves.
                                     ENDS                                      
A conference call for analysts and investors will be held at 8.00am GMT. To
access this call please dial +44 (0) 1452 555 566, conference ID 27843292. The
call will be available for reply from later today until 27 December 2007 on +44
1452 550 000; access code 27843292#.
ANALYST / INVESTOR ENQUIRIES MEDIA ENQUIRIES
Alex Dee                                   Josh Rosenstock                   
                                                                             
Tel: +44 (0) 20 7368 2336                  Tel: +44 (0) 20 7368 2327         
                                                                             
Mob: +44 (0) 7989 017 979                  Mob: +44 (0) 7921 910 914         
                                                                             
Email: alex.dee@misys.com                  Email:                            
                                           josh.rosenstock@misys.com         
About Misys plc
Misys plc (FTSE: MSY.L), provides integrated, comprehensive solutions that
deliver significant results to organisations in the financial services and
healthcare industries. We maximise value for our customers by combining our
deep knowledge of their business with our commitment to their success.
In banking and treasury & capital markets, Misys is a market leader, with over
1,200 customers, including all of the world's top 50 banks. In healthcare,
Misys is a market leader, serving more than 100,000 physicians in 18,000
practice locations and 600 home care providers. Misys employs around 4,500
people who serve customers in more than 120 countries.
We aspire to be the world's best application software and services company,
delivering results for the most important industries in the world.
Misys: Experience, Solutions, Results
2
END